惠泰医疗跌2.02%，成交额1.96亿元，主力资金净流出558.92万元

Core Viewpoint - 惠泰医疗's stock price has shown a positive trend this year, with a year-to-date increase of 21.64%, indicating strong market performance and investor interest [1][2]. Financial Performance - For the first half of 2025, 惠泰医疗 reported a revenue of 1.214 billion yuan, representing a year-on-year growth of 21.26% [2]. - The net profit attributable to shareholders for the same period was 425 million yuan, reflecting a year-on-year increase of 24.11% [2]. Shareholder Information - As of June 30, 2025, 惠泰医疗 had 4,507 shareholders, an increase of 20.12% from the previous period [2]. - The average number of circulating shares per shareholder was 31,287, which is a 20.92% increase compared to the last period [2]. Dividend Distribution - 惠泰医疗 has distributed a total of 514 million yuan in dividends since its A-share listing, with 413 million yuan distributed over the past three years [3]. Institutional Holdings - As of June 30, 2025, major institutional shareholders include 华夏上证科创板50成份ETF, holding 4.6347 million shares, an increase of 1.3341 million shares from the previous period [3]. - Other notable shareholders include 香港中央结算有限公司 and 易方达上证科创板50ETF, with increases in their holdings as well [3]. Market Activity - On September 9, 惠泰医疗's stock price decreased by 2.02%, trading at 310.88 yuan per share, with a total market capitalization of 43.838 billion yuan [1]. - The stock experienced a net outflow of 5.5892 million yuan in principal funds, indicating some selling pressure [1].